@misc{indiciae5f251190a7da,
  title = {Structure-based drug repositioning reveals ibrutinib as VEGFR2 inhibitor},
  author = {Adasme, M. F. and Parisi, D. and Van Belle, K. and Salentin, S. and Haupt, V. J. and Jennings, G. S. and Heinrich, J.-C. and Herman, J. and Sprangers, B. and Louat, T. and Moreau, Y. and Schroeder, M.},
  year = {2019},
  doi = {10.1101/678896},
  url = {https://www.biorxiv.org/content/10.1101/678896v1},
  note = {Source identifier: 10.1101/678896}
}